Advanced Oncotherapy plc (AVO.L) is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.
The Company’s focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient’s healthy tissues. Advanced Oncotherapy plc operates from three main locations: the head office in London, UK, the R&D facility ADAM S.A. (Applications of Detectors and Accelerators to Medicine) in Geneva, Switzerland with the US operations in Syracuse, NY.
